Thompson Peter A. (CIK 1357522) reported 38 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-07-02). Recent activity: Sell SION (115,844 shares), Sell SION (101 shares), Sell SION (48,546 shares), Sell SION (59,767 shares), Sell SION (184,639 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | Sionna Therapeutics, Inc. (SION) | Director | Sell | 115,844 | $5.3M |
| 2026-05-29 | Sionna Therapeutics, Inc. (SION) | Director | Sell | 101 | $4,493 |
| 2026-05-11 | Sionna Therapeutics, Inc. (SION) | Director | Sell | 48,546 | $2.2M |
| 2026-05-11 | Sionna Therapeutics, Inc. (SION) | Director | Sell | 59,767 | $2.7M |
| 2026-05-11 | Sionna Therapeutics, Inc. (SION) | Director | Sell | 184,639 | $8.5M |
| 2026-04-21 | Sionna Therapeutics, Inc. (SION) | Director | Sell | 52,397 | $2.3M |
| 2026-04-21 | Sionna Therapeutics, Inc. (SION) | Director | Sell | 2,948 | $131,245 |
| 2026-04-16 | Sionna Therapeutics, Inc. (SION) | Director | Sell | 47,814 | $2.1M |
| 2026-04-16 | Sionna Therapeutics, Inc. (SION) | Director | Sell | 235,863 | $10.5M |
| 2026-04-16 | Sionna Therapeutics, Inc. (SION) | Director | Sell | 226,906 | $10.3M |
| 2026-02-04 | Sionna Therapeutics, Inc. (SION) | Director | Sell | 1,890 | $84,237 |
| 2026-02-04 | Sionna Therapeutics, Inc. (SION) | Director | Sell | 29,063 | $1.3M |
| 2026-01-30 | Corvus Pharmaceuticals, Inc. (CRVS) | Director | Buy | 30,000 | $450,000 |
| 2026-01-30 | Corvus Pharmaceuticals, Inc. (CRVS) | Director | Buy | 15,000 | $145,500 |
| 2026-01-30 | Corvus Pharmaceuticals, Inc. (CRVS) | Director | Buy | 15,000 | $187,500 |
| 2026-01-30 | Corvus Pharmaceuticals, Inc. (CRVS) | Director | Buy | 15,000 | $54,150 |
| 2026-01-30 | Corvus Pharmaceuticals, Inc. (CRVS) | Director | Buy | 15,000 | $30,000 |
| 2026-01-30 | Corvus Pharmaceuticals, Inc. (CRVS) | Director | Buy | 15,000 | $49,050 |
| 2026-01-30 | Corvus Pharmaceuticals, Inc. (CRVS) | Director | Buy | 15,000 | $41,100 |
| 2026-01-30 | Corvus Pharmaceuticals, Inc. (CRVS) | Director | Buy | 15,000 | $39,000 |
| 2026-01-30 | Corvus Pharmaceuticals, Inc. (CRVS) | Director | Buy | 15,000 | $14,850 |
| 2026-01-30 | Corvus Pharmaceuticals, Inc. (CRVS) | Director | Buy | 15,000 | $14,550 |
| 2026-01-30 | Corvus Pharmaceuticals, Inc. (CRVS) | Director | Buy | 15,000 | $37,350 |
| 2026-01-30 | Corvus Pharmaceuticals, Inc. (CRVS) | Director | Buy | 15,000 | $24,600 |
| 2026-01-30 | Corvus Pharmaceuticals, Inc. (CRVS) | Director | Buy | 15,000 | $31,800 |
Source: SEC Form 4 filings · as of 2026-07-02